pimecrolimus
Selected indexed studies
- Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. (Eur J Dermatol, 2023) [PMID:38297923]
- Pimecrolimus: a review. (J Eur Acad Dermatol Venereol, 2003) [PMID:12941081]
- Off-label Uses of Topical Pimecrolimus. (J Cutan Med Surg, 2019) [PMID:31053034]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas. (2023) pubmed
- Pimecrolimus: a review. (2003) pubmed
- Off-label Uses of Topical Pimecrolimus. (2019) pubmed
- Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. (2015) pubmed
- Pimecrolimus in dermatology. (2009) pubmed
- Topical pimecrolimus for eczema. (2007) pubmed
- Pimecrolimus for psoriasis. (2013) pubmed
- Pimecrolimus, yet another intriguing topical immunomodulator. (2007) pubmed
- Pimecrolimus -- an anti-inflammatory drug targeting the skin. (2004) pubmed
- Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity. (2001) pubmed